Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population?

Am J Transplant. 2021 Apr;21(4):1670-1671. doi: 10.1111/ajt.16370. Epub 2020 Nov 4.

Authors

Maria A Mendoza¹, Mohammed Raja², Aasith Villavicencio¹, Shweta Anjan^{2

3}, Yoichiro Natori^{2

3}

Affiliations

¹ Department of Medicine, Division of Internal Medicine, University of Miami Miller School of Medicine, Miami, Florida.
² Department of Medicine, Division of Infectious Disease, University of Miami Miller School of Medicine, Miami, Florida.
³ Miami Transplant Institute, Jackson Health System, Miami, Florida.

No abstract available

Keywords: clinical research/practice; complication: infectious; infection and infectious agents - viral; infectious disease.

Publication types

Letter
Comment

MeSH terms

COVID-19*
Critical Illness
Humans
Organ Transplantation* / adverse effects
SARS-CoV-2
Transplant Recipients
United States